Arrowhead Research | Bienes



Assets Cambio Fecha
Agios Pharmaceuticals USD 1.66B 128.6M 2024-12
Alnylam Pharmaceuticals USD 4.24B 34.94M 2024-12
Arrowhead Research USD 1.01B 126.11M 2024-12
Incyte USD 5.44B 431.89M 2024-12
Ionis Pharmaceuticals USD 3B 77.42M 2024-12
Ligand Pharmaceuticals USD 941.77M 13.09M 2024-12
Merck USD 117.11B 426M 2024-12
Moderna USD 14.14B 1.66B 2024-12
Novartis USD 102.25B 1.28B 2024-12
Sarepta Therapeutics USD 3.96B 363.24M 2024-12
TG Therapeutics USD 577.69M 8.32M 2024-12
Ultragenyx Pharmaceutical USD 1.5B 34.91M 2024-12
Vertex Pharmaceuticals USD 22.53B 293M 2024-12
Xencor USD 951.94M 31.69M 2024-12



Arrowhead Research Bienes - Los valores actuales, los datos históricos, las previsiones, estadísticas, gráficas y calendario económico - Mar 2025.